← Leaderboards
Basil Rigas
Institute For Cancer Prevention
$10,362,739
Attributed
$10,362,739
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $973.4K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,362,739 · 8
By mechanism
R01$10,327,855 · 5
M01$34,884 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Chemoprevention”
- Charles A Coltman · Southwest Oncology Group$144,723,158
- Norman Wolmark · Nsabp Foundation, Inc.$110,141,959
- John Anthony Baron · Dartmouth College$61,176,184
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
Research focus
ChemopreventionApoptosisMalignant NeoplasmsAnimal ModelAspirinGrowthAnimalsNitric OxideCell ProliferationCancer CellSafetyBaseMediatingPreventSignal TransductionCellsCancer PreventionIn VitroPharmaceutical PreparationsCancer ControlChemopreventive AgentPreventionCessation Of LifePathway Interactions
Grant awards (43)
Phospho-sulindac for Lung Cancer Treatment$349,487
R01 · FY2019 · CA · contact PI
Phospho-sulindac for Lung Cancer Treatment$67,186
R01 · FY2019 · CA · contact PI
Phospho-sulindac for Lung Cancer Treatment$346,111
R01 · FY2018 · CA · contact PI
Phospho-sulindac for Lung Cancer Treatment$346,111
R01 · FY2017 · CA · contact PI
Phospho-sulindac for Lung Cancer Treatment$65,399
R01 · FY2016 · CA · contact PI
Phospho-sulindac for Lung Cancer Treatment$327,850
R01 · FY2015 · CA · contact PI
Phospho-sulindac for Lung Cancer Treatment$327,850
R01 · FY2014 · CA · contact PI
Phospho-valproic acid for pancreatic cancer prevention$306,522
R01 · FY2014 · CA · contact PI
Phospho-valproic acid for pancreatic cancer prevention$297,042
R01 · FY2013 · CA · contact PI
Colon Cancer Prevention with Phospho-Sulindac$295,554
R01 · FY2013 · CA · contact PI
Phospho-valproic acid for pancreatic cancer prevention$316,002
R01 · FY2012 · CA · contact PI
Colon Cancer Prevention with Phospho-Sulindac$314,419
R01 · FY2012 · CA · contact PI
No-Releasing Aspirin and Colon Cancer Prevention$318,217
R01 · FY2011 · CA · contact PI
Phospho-valproic acid for pancreatic cancer prevention$316,002
R01 · FY2011 · CA · contact PI
Colon Cancer Prevention with Phospho-Sulindac$314,419
R01 · FY2011 · CA · contact PI
No-Releasing Aspirin and Colon Cancer Prevention$328,058
R01 · FY2010 · CA · contact PI
Colon Cancer Prevention with Phospho-Sulindac$323,289
R01 · FY2010 · CA · contact PI
Phospho-valproic acid for pancreatic cancer prevention$322,101
R01 · FY2010 · CA · contact PI
No-Releasing Aspirin and Colon Cancer Prevention$328,058
R01 · FY2009 · CA · contact PI
Colon Cancer Prevention with Phospho-Sulindac$322,096
R01 · FY2009 · CA · contact PI
No-Releasing Aspirin and Colon Cancer Prevention$328,058
R01 · FY2008 · CA · contact PI
Pancreatic cancer prevention with NO-releasing NSAIDs$249,347
R01 · FY2008 · CA · contact PI
CLINICAL TRIAL: PHASE 1 DOSE SAFETY, PHARMACOKENETIC AND PHARMACODYNAMIC CLINICA$20,581
M01 · FY2008 · RR · contact PI
No-Releasing Aspirin and Colon Cancer Prevention$328,058
R01 · FY2007 · CA · contact PI
Pancreatic cancer prevention with NO-releasing NSAIDs$249,347
R01 · FY2007 · CA · contact PI
PHASE 1 DOSE SAFETY, PHARMACOKENETIC AND PHARMACODYNAMIC CLINICAL STUDY$7,369
M01 · FY2007 · RR · contact PI
Pancreatic cancer prevention with NO-releasing NSAIDs$256,794
R01 · FY2006 · CA · contact PI
PHASE I, MULTIPLE-DOSE SAFETY, PHARMACOKINETIC, PHARMACODYNAMIC CLINICAL STUDY$6,934
M01 · FY2006 · RR · contact PI
NO Releasing Aspirin and Colon Cancer Chemoprevention$318,513
R01 · FY2005 · CA
Pancreatic cancer prevention with NO-releasing NSAIDs$261,191
R01 · FY2005 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$148,654
R01 · FY2005 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$315,400
R01 · FY2004 · CA
Pancreatic Cancer Prevention with NO-releasing NSAIDs$265,900
R01 · FY2004 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$142,915
R01 · FY2004 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$94,181
R01 · FY2004 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$325,775
R01 · FY2003 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$147,436
R01 · FY2003 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$94,445
R01 · FY2003 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$325,775
R01 · FY2002 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$91,696
R01 · FY2002 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$73,830
R01 · FY2002 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$64,819
R01 · FY2002 · CA
NO Releasing Aspirin and Colon Cancer Chemoprevention$313,948
R01 · FY2001 · CA